This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Apr 21;357(9264):1291; author reply 1291-2.

doi: 10.1016/S0140-6736(00)04433-0.

Tamoxifen's effect in women with breast cancer

A Bryson, J Massey

PMID: 11421213
DOI: 10.1016/S0140-6736(00)04433-0

Comment

Tamoxifen's effect in women with breast cancer

A Bryson et al. Lancet. 2001.

. 2001 Apr 21;357(9264):1291; author reply 1291-2.

doi: 10.1016/S0140-6736(00)04433-0.

Authors

A Bryson, J Massey

PMID: 11421213
DOI: 10.1016/S0140-6736(00)04433-0

No abstract available

PubMed Disclaimer

Comment on

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Lancet. 2000 Dec 2;356(9245):1876-81. doi: 10.1016/s0140-6736(00)03258-x. Lancet. 2000. PMID: 11130383

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information